My Current Location Atlanta, GA 30308

Access Your Account

New to Healthgrades?

Join for free!

Or, sign in directly with Healthgrades:

Doctors and their Administrators:
Sign Up or Log In

Breakthroughs in Advanced Hormone-Sensitive Breast Cancer Treatment


Dennis Citrin, MD

Was this helpful? (11)
This content is selected and managed by the Healthgrades editorial staff and is brought to you by an advertising sponsor.

This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and objectivity. The content is not edited or otherwise influenced by the advertisers appearing on this page except with the possible suggestion of the broad topic area. For more information, read the HealthGrades advertising policy.

Woman and doctor

Over the last 20 years, the life expectancy of patients with metastatic breast cancer has virtually tripled. Nearly half of all patients with stage IV breast cancer are living more than five years. And we have new research and treatments to thank for that. 

Most women with advanced breast cancer have been treated in the past for early stage disease and are experiencing a recurrence. Many of these patients don’t realize that treating advanced breast cancer is a lot different than what they experienced their first time around. In fact, some of the newest therapies came out so recently that they might not have even been available when the patient was first receiving treatment.

Revolutionary treatments have increased the life expectancy rates for breast cancer patients. Watch this video for more breast cancer facts.

Medical Reviewer: William C. Lloyd III, MD, FACS Last Review Date: May 12, 2017

2017 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

Because advanced cancer is metastatic, meaning the cancer has spread to other parts of their body, the primary treatment is not surgery or radiation—we can’t just surgically remove the tumors or radiate one area of the body to kill the cancer cells. Rather, these patients need systemic drug treatment that will control the cancer throughout the body. But this doesn’t necessarily mean we immediately turn to chemotherapy, either; unlike chemo, which kills cancer cells and healthy cells, these new drugs take more specific actions to prevent cancer cells from growing and spreading in the first place.

Getting to the Root of Cancer

Understanding what causes a patient’s cancer cells to grow is the first step in determining the right treatment. Recognizing the differences in the biology of the disease has had an enormous impact on what we as medical oncologists do. Our deeper understanding of the intricate details of cancer has revolutionized oncology treatment. Fifteen years ago, we didn’t know the differences between the pathways and proteins that play a role in cancer growth; now, these terms are part of the everyday lexicon in our field.

As a result of these discoveries, we now use certain tests to analyze a tumor and identify if its growth is influenced by the reproductive hormones, estrogen and progesterone, or if it interacts with a protein called human epidermal growth factor 2 (HER2). Sometimes, breast cancer cells don’t use either of these to grow—we call this triple negative breast cancer. If your breast cancer cells grow with help from your hormones, we call it hormone receptor-positive (HR-positive) breast cancer, and if the cells grow using HER2, it’s known as HER2-positive breast cancer. When we’ve identified that hormones or HER2 are helping the cancer propagate, we use drugs that specifically act to stop the cell growth cycle and block hormones and HER2 from interacting with cancer cells. In cases of triple negative breast cancer, we’ll still turn to chemotherapy, as we don’t yet know what factors are causing the cancer to grow in those patients.

New Treatments Improve Lifespan and Quality of Life

About 75% of breast cancer patients have HR-positive breast cancer. For decades, we’ve treated this type of cancer with hormone therapy, also known as endocrine therapy. One of our goals in these cases is to drastically lower the levels of reproductive hormones so the cancer cells can’t use the hormones to grow. We also use medications to block the cancer cells from being able to interact with the hormones. In postmenopausal women, we’ll prescribe a class of drugs called aromatase inhibitors, and these treatments effectively help breast cancer patients control their disease—for a while.

We’ve found that over time, these hormone therapies stop working to control cancer cell growth. After several years, a resistance develops and the cancer begins to progress again. That’s where these new drugs come into play. In only the last few years, researchers have developed medications called CDK4/6 inhibitors. These drugs interfere with the process of cell growth. When patients take CDK4/6 inhibitors in combination with hormone therapies, these new drugs help delay the patient becoming resistant to hormone therapies—their bodies continue to respond to the medication for much, much longer.

THIS CONTENT DOES NOT PROVIDE MEDICAL ADVICE. This content is provided for informational purposes and reflects the opinions of the author. It is not a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified healthcare professional regarding your health. If you think you may have a medical emergency, contact your doctor immediately or call 911.

Dennis Citrin, MD

Dennis Citrin, MD, is a board-certified oncologist specializing in breast cancer treatment with Cancer Treatment Centers of America at the Midwestern Regional Medical Center. He’s the author of the book, “Knowledge is Power: What Every Woman Should Know About Breast Cancer.” View his Healthgrades profile >

Was this helpful? (11)

© 2017 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

You Might Also Like

What You Need to Know About Breast Cancer

Understand the risks associated with breast cancer and learn about new treatment advances.

The Different Stages of Breast Cancer

Breast cancer staging describes the extent of cancer in the body. Here is a summary of the stages.

Share via Email


Breast Cancer: Why See a Specialist?


7 Things to Expect During Metastatic Breast Cancer Treatment

Up Next

7 Things to Expect During Metastatic Breast Cancer Treatment